ClinicalTrials.Veeva
Menu

Find clinical trials for Prostate Cancer in Indianapolis, IN

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Prostatic Cancer
Cancer
Carcinoma
Hypersensitivity
Recurrence
Adenocarcinoma
Breast Cancer

Prostate Cancer trials near Indianapolis, IN, USA:

CYTALUX™for the Intraoperative Imaging of Prostate Cancer

prostatectomy and lymph node dissection for biopsy confirmed prostate cancer.The U.S. Food and Drug Administration (FDA) has approv...

Enrolling
Prostate Cancer
Diagnostic Test: Cytalux™ (pafolacianine) for fluorescent imaging

Phase 2

Indiana University
Indiana University

Indianapolis, Indiana, United States and 2 other locations

This is a prospective, open-label Phase 3 study to evaluate copper Cu 64 PSMA I\&T injection for PET/CT imaging in patients with recurrent prostate...

Enrolling
Biochemical Recurrence of Malignant Neoplasm of Prostate
Prostate Adenocarcinoma
Drug: Copper Cu 64 PSMA I&T

Phase 3

Curium

Indianapolis, Indiana, United States and 21 other locations

This is a randomized pilot study of Coronary CT Angiography (CCTA) for coronary atherosclerosis vs. Usual Care in patients with prostate cancer...

Enrolling
Prostate Cancer
Device: Coronary CT Angiography (CCTA)
Indiana University
Indiana University

Indianapolis, Indiana, United States

This was a randomized study to evaluate the risk of major adverse cardiovascular events (MACE) for relugolix compared with leuprolide acetate. Enroll...

Active, not recruiting
Prostate Cancer
Drug: Leuprolide Acetate
Drug: Relugolix

Phase 3

Sumitomo Pharma
Sumitomo Pharma

Greenwood, Indiana, United States and 107 other locations

This is a phase 1 study to assess the safety and tolerability of ARX517 in adult subjects with Metastatic Castration-Resistant Prostate Cancer...

Enrolling
Prostate Cancer
Drug: ARX517

Phase 1

Ambrx

Indianapolis, Indiana, United States and 8 other locations

Evaluate the safety and tolerability of AMG 509 in adult participants and determine the maximum tolerated dose (MTD) or recommended phase 2 dose (RP2...

Enrolling
Prostate Cancer
Drug: Abiraterone
Drug: Enzalutamide

Phase 1

Amgen
Amgen

Indianapolis, Indiana, United States and 50 other locations

To evaluate the safety and tolerability of Tarlatamab and will determine the maximum tolerated dose (MTD) or recommended phase 2 dose (RP2D).

Active, not recruiting
Neuroendocrine Prostate Cancer
Drug: Tarlatamab

Phase 1

Amgen
Amgen

Indianapolis, Indiana, United States and 20 other locations

Initial performance of Ga-68-P16-093 in prostate cancer patients including dosimetry and preliminary efficacy evaluation in BCR pat ...

Active, not recruiting
Prostate Cancer Recurrent
Prostate Cancer
Drug: Ga-68 P16-093 PET/CT scan

Phase 1, Phase 2

Five Eleven Pharma

Indianapolis, Indiana, United States

Recently updated

The purpose of this study is to evaluate the efficacy and safety of apalutamide in adult men with high-risk non-metastatic castration-resistant prostate...

Active, not recruiting
Prostatic Neoplasms
Drug: Apalutamide
Drug: Placebo

Phase 3

Aragon Pharmaceuticals

Carmel, Indiana, United States and 388 other locations

pharmacodynamics, and preliminary efficacy of AZD5305 when given in combination with new hormonal agents (NHAs) in patients with Metastatic Prostate...

Enrolling
Metastatic Prostate Cancer
Drug: AZD5305
Drug: Enzalutamide

Phase 1, Phase 2

AstraZeneca
AstraZeneca

Indianapolis, Indiana, United States and 26 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems